Can't I have a normal Friday night? 1. G turned
Post# of 30027
(Total Views: 562)
Posted On: 09/27/2019 11:43:56 PM
.jpg)
Can't I have a normal Friday night?
1. G turned that lawsuit into shares issued at $0.10 ish. Win. That's done regardless of whether Reg A works out.
2. Current shares O/S 252,504,841
3. Series E and H appear ready to partially participate in this adventure.
4. Best Efforts offering, so no promises this is succcesful
5. 50,000,000 are going to be offered. That number tells us a lot given the goal is to raise $X and our current O/S is X, and further shares to be issued are X.
6. The price per share for sale will be $0.10. At times in the past I have shouted arbitrage from the roof tops. I'll be honest, I do not quite know what the point of raising $5M is when we're $35M in debt unless it's part of an iterative process of increasing valuation.
7. The funds raised per this offering will be utilized for working capital, launch of first hemp-based product line via Joint Venture with The Alchemist’s Kitchen, retirement of securities, discounted trade payables and certain other obligations of the Company.
8. They're planning on raising this money with non US investors through NY.
9. There will be amendments. This is still sloppy in places.
10. full 3rd party valuations for both ESS and Eltoprazine are in the filing. Get on SEC.gov
1. G turned that lawsuit into shares issued at $0.10 ish. Win. That's done regardless of whether Reg A works out.
2. Current shares O/S 252,504,841
3. Series E and H appear ready to partially participate in this adventure.
4. Best Efforts offering, so no promises this is succcesful
5. 50,000,000 are going to be offered. That number tells us a lot given the goal is to raise $X and our current O/S is X, and further shares to be issued are X.
6. The price per share for sale will be $0.10. At times in the past I have shouted arbitrage from the roof tops. I'll be honest, I do not quite know what the point of raising $5M is when we're $35M in debt unless it's part of an iterative process of increasing valuation.
7. The funds raised per this offering will be utilized for working capital, launch of first hemp-based product line via Joint Venture with The Alchemist’s Kitchen, retirement of securities, discounted trade payables and certain other obligations of the Company.
8. They're planning on raising this money with non US investors through NY.
9. There will be amendments. This is still sloppy in places.
10. full 3rd party valuations for both ESS and Eltoprazine are in the filing. Get on SEC.gov
(1)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼